Agilent Technologies Prices $400 Million of Senior Notes
News Sep 11, 2012
Agilent Technologies Inc. announced the pricing of a series of its senior notes in an aggregate principal amount of $400 million, in an underwritten, registered public offering. The notes will mature in October 2022 and will bear interest at an annual rate of 3.20 percent. The offering is expected to close on September 13, 2012, subject to customary closing conditions.
Barclays Capital Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers.
Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained from:
Barclays Capital Inc.
745 Seventh Avenue
New York, NY 10019
J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Merrill Lynch, Pierce, Fenner & Smith Inc.
One Bryant Park
New York, NY 10036
Electronic copies of the prospectus supplement and accompanying prospectus are also available on the Securities and Exchange Commission website at www.sec.gov.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Advantage of Breastfeeding to Increase Mother-Child BondNews
Researchers have found that the molecule RAGE, on the intestinal epithelium, transports oxytocin into the blood even after neonate gut closure. This finding suggests breastfeeding and oral oxytocin administration is advantageous to increase its concentration in blood and mother-child bond.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE